Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
29,048
Total Claims
$1.5M
Drug Cost
719
Beneficiaries
$2,078
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+116%
Opioid rate vs peers
5.6% vs 2.6% avg
+95%
Cost per patient vs peers
$2,078 vs $1,068 avg
+67%
Brand preference vs peers
15.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
5.6%
Opioid Rate
1,621
Opioid Claims
$48K
Opioid Cost
17.7%
Long-Acting Rate
Brand vs Generic
Brand: 4,342 claims · $924K
Generic: 24,577 claims · $567K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 913 | $259K |
| Rivaroxaban | 243 | $68K |
| Deutetrabenazine | 11 | $51K |
| Rifaximin | 19 | $45K |
| Insulin Detemir | 123 | $40K |
| Collagenase Clostridium Hist. | 69 | $29K |
| Insulin Aspart | 73 | $23K |
| Efavirenz/Emtricit/Tenofovr Df | 12 | $22K |
| Potassium Chloride | 935 | $22K |
| Epoetin Alfa | 35 | $19K |
| Divalproex Sodium | 323 | $19K |
| Insulin Detemir | 50 | $18K |
| Albuterol Sulfate | 183 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 94 | $17K |
| Duloxetine Hcl | 271 | $17K |
Prescribing Profile
Patient Profile
81
Avg Age
68%
Female
3.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About